Use Case
White Papers, Case Studies, Reports
Medable platform speeds diabetes study startup by 50%
eCOA
6 min
A top 10 pharmaceutical company approached Medable seeking support for their Phase III diabetes study in the highly competitive weight loss market. Their primary goal was toreduce the client’s average study build timelines from 16-20 weeks, down to just 8 weeks,a reduction of more than 50%.
See how Medable was able to meet the customer's goal with this case study.
Speakers
No items found.
White Papers, Case Studies, Reports
Record-breaking enrollment achieved in weight-loss study
A top 10 pharmaceutical company approached Medable seeking support for their Phase III diabetes study. Their primary goal was to reduce the participant enrollment phase timeline to get the study underway as quickly as possible.